Molecular insights into Down syndrome-associated leukemia

Paresh Vyas1, John D Crispino

  • 1Department of Haematology, MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.

Summary

Mutations in the GATA1 gene are crucial for leukemia development in children with Down syndrome. However, these GATA1 mutations alone are insufficient, requiring additional genetic events for disease onset.